Nippon Chemiphar Co., Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2016; Revises Earnings Guidance for the Full Year Ending March 31, 2017
January 30, 2017
Share
Nippon Chemiphar Co., Ltd. reported earnings results for the third quarter ended December 31, 2016. For the quarter, the company reported net sales of ¥26,886 million against ¥26,914 million a year ago. Operating income was ¥2,294 million against ¥2,451 million a year ago. Income before income taxes and minority interests was ¥2,378 million against ¥2,416 million a year ago. Net income attributable to owners of the parent was ¥1,688 million against ¥1,612 million a year ago. Book value per share as at December 31, 2016 was ¥4,461.44 against ¥4,194.25 a year ago. Earnings per share were ¥433.41 against ¥409.66 a year ago. Capital expenditure was ¥2,269 million against ¥536 million a year ago.
For the year ending March 31, 2017, the company expects net sales of ¥35,500 million against previously reported guidance of ¥38,000 million. Operating income is expected to be ¥2,800 million, net income attributable to owners of the parent of ¥1,850 million. EPS is expected to be ¥474.79 per share. Capital expenditure is expected to be ¥2,900 million. Depreciation and amortization is expected to be ¥1,250 million.
NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Companyâs Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.
Nippon Chemiphar Co., Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2016; Revises Earnings Guidance for the Full Year Ending March 31, 2017